Annual Shareholders Equity
$32.52 M
+$32.56 M+86818.67%
December 1, 2023
Summary
- As of March 9, 2025, BLAC annual stockholders equity is $32.52 million, with the most recent change of +$32.56 million (+86818.67%) on December 1, 2023.
- During the last 3 years, BLAC annual shareholders equity has risen by +$32.52 million (+2709858.33%).
Performance
BLAC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$14.91 M
-$230.90 K-1.52%
September 1, 2024
Summary
- As of March 9, 2025, BLAC quarterly stockholders equity is $14.91 million, with the most recent change of -$230.90 thousand (-1.52%) on September 1, 2024.
- Over the past year, BLAC quarterly shareholders equity has stayed the same.
Performance
BLAC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BLAC Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | 0.0% |
| 3 y3 years | +10000.0% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
BLAC Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.1% | -78.4% | -100.3% |
| 5 y | 5-year | at high | -100.1% | -78.4% | -100.3% |
| alltime | all time | at high | -100.1% | -78.4% | -100.3% |
Bellevue Life Sciences Acquisition Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.91 M(-1.5%) |
| Jun 2024 | - | $15.15 M(-53.3%) |
| Mar 2024 | - | $32.46 M(-0.2%) |
| Dec 2023 | $32.52 M | $32.52 M(-52.8%) |
| Sep 2023 | - | $68.96 M(+0.1%) |
| Jun 2023 | - | $68.88 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $68.58 M(<-9900.0%) |
| Dec 2022 | -$37.50 K(+1685.7%) | -$37.50 K(+60.9%) |
| Sep 2022 | - | -$23.30 K(+628.1%) |
| Jun 2022 | - | -$3200.00(+52.4%) |
| Dec 2021 | -$2100.00(-275.0%) | -$2100.00 |
| Dec 2020 | $1200.00 | - |
FAQ
- What is Bellevue Life Sciences Acquisition annual stockholders equity?
- What is the all time high annual shareholders equity for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition annual shareholders equity year-on-year change?
- What is Bellevue Life Sciences Acquisition quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition quarterly shareholders equity year-on-year change?
What is Bellevue Life Sciences Acquisition annual stockholders equity?
The current annual shareholders equity of BLAC is $32.52 M
What is the all time high annual shareholders equity for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high annual stockholders equity is $32.52 M
What is Bellevue Life Sciences Acquisition annual shareholders equity year-on-year change?
Over the past year, BLAC annual stockholders equity has changed by +$32.56 M (+86818.67%)
What is Bellevue Life Sciences Acquisition quarterly stockholders equity?
The current quarterly shareholders equity of BLAC is $14.91 M
What is the all time high quarterly shareholders equity for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high quarterly stockholders equity is $68.96 M
What is Bellevue Life Sciences Acquisition quarterly shareholders equity year-on-year change?
Over the past year, BLAC quarterly stockholders equity has changed by $0.00 (0.00%)